Pathogenic role of glial cells in Parkinson's disease

被引:220
|
作者
Teismann, P
Tieu, K
Cohen, O
Choi, DK
Wu, DC
Marks, D
Vila, M
Jackson-Lewis, V
Przedborski, S
机构
[1] Columbia Univ, Dept Neurol, Movement Disorder Div, New York, NY 10032 USA
[2] Mamaroneck High Sch, Mamaroneck, NY USA
[3] Columbia Univ, Dept Pathol, New York, NY 10032 USA
关键词
astrocyte; gliosis; IL-1; beta; iNOS; microglia; MPTP; neurodegeneration; Parkinson's disease;
D O I
10.1002/mds.10332
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Parkinson's disease (PD) is a common neurodegenerative disorder characterized by the progressive loss of the dopaminergic neurons in the substantia nigra pars compacta (SNpc). The loss of these neurons is associated with a glial response composed mainly of activated microglial cells and, to a lesser extent, of reactive astrocytes. This glial response may be the source of trophic factors and can protect against reactive oxygen species and glutamate. Alternatively, this glial response can also mediate a variety of deleterious events related to the production of pro-oxidant reactive species, and pro-inflammatory prostaglandin and cytokines. We discuss the potential protective and deleterious effects of glial cells in the SNpc of PD and examine how those factors may contribute to the pathogenesis of this disease. (C) 2002 Movement Disorder Society.
引用
收藏
页码:121 / 129
页数:9
相关论文
共 50 条
  • [31] Nicotinic Acetylcholine Receptors in Glial Cells as Molecular Target for Parkinson's Disease
    Soares, Erica Novaes
    Costa, Ana Carla dos Santos
    Ferrolho, Gabriel de Jesus
    Ureshino, Rodrigo Portes
    Getachew, Bruk
    Costa, Silvia Lima
    da Silva, Victor Diogenes Amaral
    Tizabi, Yousef
    CELLS, 2024, 13 (06)
  • [32] The role of glial cells in neuroinflammation in the context of Alzheimer's disease
    Ferreira, Rafaella
    Heimfarth, Luana
    Ferreira, Sergio
    JOURNAL OF NEUROCHEMISTRY, 2023, 166 : 38 - 38
  • [33] Glial iron sequestration and Parkinson's disease
    Schipper, HM
    JOURNAL OF NEUROCHEMISTRY, 1998, 70 : S76 - S76
  • [34] Glial phagocytic clearance in Parkinson's disease
    Tremblay, Marie-Eve
    Cookson, Mark R.
    Civiero, Laura
    MOLECULAR NEURODEGENERATION, 2019, 14 (1)
  • [35] Glial cells as a target for the development of new therapies for treating Parkinson's disease
    Muramatsu, Y
    Araki, T
    DRUG NEWS & PERSPECTIVES, 2002, 15 (09) : 586 - 590
  • [36] Nurr1 in Glial Cells as a Disease-Modifying Target for Parkinson's Disease
    Tjalkens, Ronald B.
    Safe, Stephen
    NEUROTHERAPEUTICS, 2015, 12 (03) : 681 - 681
  • [37] The role of noncoding RNAs in Parkinson’s disease: biomarkers and associations with pathogenic pathways
    Ming-Che Kuo
    Sam Chi-Hao Liu
    Ya-Fang Hsu
    Ruey-Meei Wu
    Journal of Biomedical Science, 28
  • [38] The role of noncoding RNAs in Parkinson's disease: biomarkers and associations with pathogenic pathways
    Kuo, Ming-Che
    Liu, Sam Chi-Hao
    Hsu, Ya-Fang
    Wu, Ruey-Meei
    JOURNAL OF BIOMEDICAL SCIENCE, 2021, 28 (01)
  • [39] The role of natural killer cells in Parkinson's disease
    Earls, Rachael H.
    Lee, Jae-Kyung
    EXPERIMENTAL AND MOLECULAR MEDICINE, 2020, 52 (09): : 1517 - 1525
  • [40] Role of Neural Stem Cells in Parkinson's Disease
    Millan-Guerrero, Rebeca
    CURRENT SIGNAL TRANSDUCTION THERAPY, 2011, 6 (03) : 337 - 340